Description

Simple

Clinical

Overview

Pharmacology

Indication

Information currently not available.

Pharmacodynamic

Information currently not available.

Mechanism of action

Information currently not available.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with Ferulic acid
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)
(1,2,6,7-3H)Testosterone
(1,2,6,7-3H)Testosterone may increase the anticoagulant activities of Ferulic acid.
(R)-warfarin
The risk or severity of bleeding can be increased when Ferulic acid is combined with (R)-warfarin.
(S)-Warfarin
The risk or severity of bleeding can be increased when Ferulic acid is combined with (S)-Warfarin.
1-benzylimidazole
1-benzylimidazole may decrease the antihypertensive activities of Ferulic acid.
1-Testosterone
1-Testosterone may increase the anticoagulant activities of Ferulic acid.
18-methyl-19-nortestosterone
18-methyl-19-nortestosterone may increase the anticoagulant activities of Ferulic acid.
2,5-Dimethoxy-4-ethylamphetamine
2,5-Dimethoxy-4-ethylamphetamine may decrease the antihypertensive activities of Ferulic acid.
2,5-Dimethoxy-4-ethylthioamphetamine
2,5-Dimethoxy-4-ethylthioamphetamine may decrease the antihypertensive activities of Ferulic acid.
3,5-Diiodotyrosine
3,5-Diiodotyrosine may increase the anticoagulant activities of Ferulic acid.
4-Bromo-2,5-dimethoxyamphetamine
4-Bromo-2,5-dimethoxyamphetamine may decrease the antihypertensive activities of Ferulic acid.
4-hydroxycoumarin
The risk or severity of bleeding can be increased when Ferulic acid is combined with 4-hydroxycoumarin.
4-Hydroxytestosterone
4-Hydroxytestosterone may increase the anticoagulant activities of Ferulic acid.
4-Methoxyamphetamine
4-Methoxyamphetamine may decrease the antihypertensive activities of Ferulic acid.
5-methoxy-N,N-dimethyltryptamine
5-methoxy-N,N-dimethyltryptamine may decrease the antihypertensive activities of Ferulic acid.
5beta-dihydrotestosterone
5beta-dihydrotestosterone may increase the anticoagulant activities of Ferulic acid.
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Ferulic acid.
Abciximab
The risk or severity of bleeding can be increased when Abciximab is combined with Ferulic acid.
Abediterol
Abediterol may decrease the antihypertensive activities of Ferulic acid.
Acebutolol
The therapeutic efficacy of Ferulic acid can be increased when used in combination with Acebutolol.
Aceclofenac
The risk or severity of bleeding and hemorrhage can be increased when Aceclofenac is combined with Ferulic acid.